GlassScriptPhysician profile
Avraham N Cohen
NPI 1144269283
$2,361.43
in general payments reported to CMS, 2019-2025
22 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $102 · 2021: $159 · 2022: $506 · 2023: $688 · 2024: $221 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $630.30 | 2019-2025 | Clareon, Hydrus Microstent, Simbrinza |
| Johnson & Johnson Surgical Vision, INC. | $280.33 | 2019-2023 | Tecnis Iol, Veritas Vision System |
| Oyster Point Pharma, INC. | $233.58 | 2022-2024 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $198.92 | 2022-2024 | Durysta |
| New World Medical,INC. | $176.41 | 2022 | |
| Aerie Pharmaceuticals, INC. | $138.65 | 2019-2021 | |
| Sight Sciences, INC. | $124.85 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $121.28 | 2019-2025 | Idosetr |
| Mallinckrodt Hospital Products INC. | $99.85 | 2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $80.51 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $41.94 | 2022-2023 | Soliris |
| Allergan, INC. | $37.16 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.21 | 2020-2021 | |
| Ivantis, INC | $28.79 | 2019 | |
| Thea Pharma INC. | $22.65 | 2024 | Iyuzeh |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Harrow Eye, LLC | $18.13 | 2025 | Triesence |
| Beaver-Visitec International, INC. | $17.33 | 2023 | |
| Novartis Pharmaceuticals Corporation | $15.19 | 2019 | |
| Horizon Therapeutics Plc | $15.01 | 2022 | |
| Ocular Therapeutix, INC. | $13.42 | 2019 | |
| Eyevance Pharmaceuticals LLC | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avraham Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.